{"id":"https://openalex.org/W3083259192","doi":"https://doi.org/10.3747/co.27.5459","title":"A Cost\u2013Utility Analysis of Atezolizumab in the Second-Line Treatment of Patients with Metastatic Bladder Cancer","display_name":"A Cost\u2013Utility Analysis of Atezolizumab in the Second-Line Treatment of Patients with Metastatic Bladder Cancer","publication_year":2020,"publication_date":"2020-08-01","ids":{"openalex":"https://openalex.org/W3083259192","doi":"https://doi.org/10.3747/co.27.5459","mag":"3083259192","pmid":"https://pubmed.ncbi.nlm.nih.gov/32905260","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7467791"},"language":"en","primary_location":{"id":"doi:10.3747/co.27.5459","doi":"https://doi.org/10.3747/co.27.5459","is_oa":true,"landing_page_url":"https://doi.org/10.3747/co.27.5459","pdf_url":"https://www.mdpi.com/1718-7729/27/4/5459/pdf?version=1609334600","source":{"id":"https://openalex.org/S113449754","display_name":"Current Oncology","issn_l":"1198-0052","issn":["1198-0052","1718-7729"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/1718-7729/27/4/5459/pdf?version=1609334600","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017907374","display_name":"Ambica Parmar","orcid":"https://orcid.org/0000-0002-0597-3843","observed_orcids":["https://orcid.org/0000-0002-0597-3843"]},"institutions":[{"id":"https://openalex.org/I1323843004","display_name":"Sunnybrook Health Science Centre","ror":"https://ror.org/03wefcv03","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I4210167439","display_name":"Sunnybrook Hospital","ror":"https://ror.org/008kn1a71","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004","https://openalex.org/I4210167439"]},{"id":"https://openalex.org/I4405271711","display_name":"Odette Cancer Centre","ror":"https://ror.org/02ww1s787","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004","https://openalex.org/I4405271711"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"A. Parmar","raw_affiliation_strings":["Institute of Health Policy, Management and Evaluative Sciences, University of Toronto","Odette Cancer Centre, Sunnybrook Health Sciences Centre","Institute of Health Policy, Management and Evaluative Sciences, University of Toronto, Toronto, ON, Canada","Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Health Policy, Management and Evaluative Sciences, University of Toronto","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Odette Cancer Centre, Sunnybrook Health Sciences Centre","institution_ids":["https://openalex.org/I1323843004","https://openalex.org/I4210167439","https://openalex.org/I4405271711"]},{"raw_affiliation_string":"Institute of Health Policy, Management and Evaluative Sciences, University of Toronto, Toronto, ON, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada","institution_ids":["https://openalex.org/I1323843004","https://openalex.org/I4210167439","https://openalex.org/I4405271711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038883240","display_name":"Marina Richardson","orcid":"https://orcid.org/0000-0002-8278-7454","observed_orcids":["https://orcid.org/0000-0002-8278-7454"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"M. Richardson","raw_affiliation_strings":["Institute of Health Policy, Management and Evaluative Sciences, University of Toronto","Institute of Health Policy, Management and Evaluative Sciences, University of Toronto, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Health Policy, Management and Evaluative Sciences, University of Toronto","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Institute of Health Policy, Management and Evaluative Sciences, University of Toronto, Toronto, ON, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074186003","display_name":"Peter C. Coyte","orcid":"https://orcid.org/0000-0002-2993-3491","observed_orcids":["https://orcid.org/0000-0002-2993-3491"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"P.C. Coyte","raw_affiliation_strings":["Institute of Health Policy, Management and Evaluative Sciences, University of Toronto","Toronto Health Economics and Technology Assessment Collaboration, University Health Network","Institute of Health Policy, Management and Evaluative Sciences, University of Toronto, Toronto, ON, Canada","Toronto Health Economics and Technology Assessment Collaboration, University Health Network, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Health Policy, Management and Evaluative Sciences, University of Toronto","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Toronto Health Economics and Technology Assessment Collaboration, University Health Network","institution_ids":["https://openalex.org/I1325899441"]},{"raw_affiliation_string":"Institute of Health Policy, Management and Evaluative Sciences, University of Toronto, Toronto, ON, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Toronto Health Economics and Technology Assessment Collaboration, University Health Network, Toronto, ON, Canada","institution_ids":["https://openalex.org/I1325899441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087125249","display_name":"Susanna Yee-Shan Cheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1323843004","display_name":"Sunnybrook Health Science Centre","ror":"https://ror.org/03wefcv03","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004"]},{"id":"https://openalex.org/I4210167439","display_name":"Sunnybrook Hospital","ror":"https://ror.org/008kn1a71","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004","https://openalex.org/I4210167439"]},{"id":"https://openalex.org/I4405271711","display_name":"Odette Cancer Centre","ror":"https://ror.org/02ww1s787","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004","https://openalex.org/I4405271711"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"S. Cheng","raw_affiliation_strings":["Odette Cancer Centre, Sunnybrook Health Sciences Centre","Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Odette Cancer Centre, Sunnybrook Health Sciences Centre","institution_ids":["https://openalex.org/I1323843004","https://openalex.org/I4210167439","https://openalex.org/I4405271711"]},{"raw_affiliation_string":"Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada","institution_ids":["https://openalex.org/I1323843004","https://openalex.org/I4210167439","https://openalex.org/I4405271711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032844648","display_name":"Beate Sander","orcid":"https://orcid.org/0000-0003-2128-9133","observed_orcids":["https://orcid.org/0000-0003-2128-9133"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I4210125326","display_name":"Public Health Ontario","ror":"https://ror.org/025z8ah66","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4210125326"]},{"id":"https://openalex.org/I4210147079","display_name":"Institute for Clinical Evaluative Sciences","ror":"https://ror.org/05p6rhy72","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I4210147079"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"B. Sander","raw_affiliation_strings":["Institute of Health Policy, Management and Evaluative Sciences, University of Toronto","Public Health Ontario","Toronto Health Economics and Technology Assessment Collaboration, University Health Network","ices, University of Toronto","ICES, University of Toronto, Toronto, ON, Canada","Institute of Health Policy, Management and Evaluative Sciences, University of Toronto, Toronto, ON, Canada","Public Health Ontario, Toronto, ON, Canada","Toronto Health Economics and Technology Assessment Collaboration, University Health Network, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Health Policy, Management and Evaluative Sciences, University of Toronto","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Public Health Ontario","institution_ids":["https://openalex.org/I4210125326"]},{"raw_affiliation_string":"Toronto Health Economics and Technology Assessment Collaboration, University Health Network","institution_ids":["https://openalex.org/I1325899441"]},{"raw_affiliation_string":"ices, University of Toronto","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"ICES, University of Toronto, Toronto, ON, Canada","institution_ids":["https://openalex.org/I185261750","https://openalex.org/I4210147079"]},{"raw_affiliation_string":"Institute of Health Policy, Management and Evaluative Sciences, University of Toronto, Toronto, ON, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Public Health Ontario, Toronto, ON, Canada","institution_ids":["https://openalex.org/I4210125326"]},{"raw_affiliation_string":"Toronto Health Economics and Technology Assessment Collaboration, University Health Network, Toronto, ON, Canada","institution_ids":["https://openalex.org/I1325899441"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008282524","display_name":"Kelvin Chan","orcid":"https://orcid.org/0000-0002-2501-3057","observed_orcids":["https://orcid.org/0000-0002-2501-3057"]},"institutions":[{"id":"https://openalex.org/I1323843004","display_name":"Sunnybrook Health Science Centre","ror":"https://ror.org/03wefcv03","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I4210153208","display_name":"Canadian Centre for Applied Research in Cancer Control","ror":"https://ror.org/05wpaeg31","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4210153208"]},{"id":"https://openalex.org/I4210167439","display_name":"Sunnybrook Hospital","ror":"https://ror.org/008kn1a71","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004","https://openalex.org/I4210167439"]},{"id":"https://openalex.org/I4405271711","display_name":"Odette Cancer Centre","ror":"https://ror.org/02ww1s787","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004","https://openalex.org/I4405271711"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"K.K.W. Chan","raw_affiliation_strings":["Canadian Centre for Applied Research in Cancer Control, Toronto, ON","Institute of Health Policy, Management and Evaluative Sciences, University of Toronto","Odette Cancer Centre, Sunnybrook Health Sciences Centre","Canadian Centre for Applied Research in Cancer Control, Toronto, ON, Canada","Institute of Health Policy, Management and Evaluative Sciences, University of Toronto, Toronto, ON, Canada","Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Canadian Centre for Applied Research in Cancer Control, Toronto, ON","institution_ids":["https://openalex.org/I4210153208"]},{"raw_affiliation_string":"Institute of Health Policy, Management and Evaluative Sciences, University of Toronto","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Odette Cancer Centre, Sunnybrook Health Sciences Centre","institution_ids":["https://openalex.org/I1323843004","https://openalex.org/I4210167439","https://openalex.org/I4405271711"]},{"raw_affiliation_string":"Canadian Centre for Applied Research in Cancer Control, Toronto, ON, Canada","institution_ids":["https://openalex.org/I4210153208"]},{"raw_affiliation_string":"Institute of Health Policy, Management and Evaluative Sciences, University of Toronto, Toronto, ON, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada","institution_ids":["https://openalex.org/I1323843004","https://openalex.org/I4210167439","https://openalex.org/I4405271711"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5008282524"],"corresponding_institution_ids":["https://openalex.org/I1323843004","https://openalex.org/I185261750","https://openalex.org/I4210153208","https://openalex.org/I4210167439","https://openalex.org/I4405271711"],"apc_list":{"value":2200,"currency":"CHF","value_usd":2654},"apc_paid":{"value":2200,"currency":"CHF","value_usd":2654},"fwci":1.1977,"has_fulltext":true,"cited_by_count":12,"citation_normalized_percentile":{"value":0.85212022,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"27","issue":"4","first_page":"386","last_page":"394"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9394999742507935,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9394999742507935,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.05209999904036522,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.00559999980032444,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":1.0},{"id":"https://openalex.org/keywords/metastatic-bladder-cancer","display_name":"metastatic bladder cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.972000002861023},{"id":"https://openalex.org/keywords/cost-utility-analysis","display_name":"cost-utility analysis","score":0.8579999804496765},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.8149999976158142},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.8180000185966492},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.5059999823570251},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.9129999876022339},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6399999856948853},{"id":"https://openalex.org/keywords/end-of-life-care","display_name":"end-of-life care","score":0.7599999904632568}],"concepts":[{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.9503234624862671},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8580092191696167},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5502578616142273},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4916992783546448},{"id":"https://openalex.org/C515549039","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost-effectiveness analysis","level":3,"score":0.483650803565979},{"id":"https://openalex.org/C64332521","wikidata":"https://www.wikidata.org/wiki/Q614165","display_name":"Quality-adjusted life year","level":3,"score":0.4659738540649414},{"id":"https://openalex.org/C127454912","wikidata":"https://www.wikidata.org/wiki/Q942582","display_name":"Cost\u2013benefit analysis","level":2,"score":0.46247756481170654},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.4526588022708893},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4444635212421417},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.41913938522338867},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.4151454269886017},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4062678813934326},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.3919147253036499},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3674207925796509},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.17270195484161377},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.10186183452606201},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.08009997010231018},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0730343759059906},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077982","descriptor_name":"Progression-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.3747/co.27.5459","doi":"https://doi.org/10.3747/co.27.5459","is_oa":true,"landing_page_url":"https://doi.org/10.3747/co.27.5459","pdf_url":"https://www.mdpi.com/1718-7729/27/4/5459/pdf?version=1609334600","source":{"id":"https://openalex.org/S113449754","display_name":"Current Oncology","issn_l":"1198-0052","issn":["1198-0052","1718-7729"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Oncology","raw_type":"journal-article"},{"id":"pmid:32905260","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32905260","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current oncology (Toronto, Ont.)","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7467791","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7467791/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Curr Oncol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.3747/co.27.5459","doi":"https://doi.org/10.3747/co.27.5459","is_oa":true,"landing_page_url":"https://doi.org/10.3747/co.27.5459","pdf_url":"https://www.mdpi.com/1718-7729/27/4/5459/pdf?version=1609334600","source":{"id":"https://openalex.org/S113449754","display_name":"Current Oncology","issn_l":"1198-0052","issn":["1198-0052","1718-7729"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1177431072","display_name":null,"funder_award_id":"2015\u2010703549","funder_id":"https://openalex.org/F4320334576","funder_display_name":"Canadian Cancer Society Research Institute"},{"id":"https://openalex.org/G1311391645","display_name":null,"funder_award_id":"#2015-703549","funder_id":"https://openalex.org/F4320313708","funder_display_name":"Canadian Centre for Applied Research in Cancer Control"},{"id":"https://openalex.org/G4367800482","display_name":null,"funder_award_id":"703549","funder_id":"https://openalex.org/F4320334576","funder_display_name":"Canadian Cancer Society Research Institute"}],"funders":[{"id":"https://openalex.org/F4320313708","display_name":"Canadian Centre for Applied Research in Cancer Control","ror":"https://ror.org/05wpaeg31"},{"id":"https://openalex.org/F4320334576","display_name":"Canadian Cancer Society Research Institute","ror":"https://ror.org/017343w90"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3083259192.pdf","grobid_xml":"https://content.openalex.org/works/W3083259192.grobid-xml"},"referenced_works_count":35,"referenced_works":["https://openalex.org/W2029465486","https://openalex.org/W2085826031","https://openalex.org/W2092977595","https://openalex.org/W2102116016","https://openalex.org/W2103257412","https://openalex.org/W2135369095","https://openalex.org/W2152762320","https://openalex.org/W2153294383","https://openalex.org/W2203611750","https://openalex.org/W2264465777","https://openalex.org/W2266179496","https://openalex.org/W2286756681","https://openalex.org/W2289712604","https://openalex.org/W2304807567","https://openalex.org/W2480089048","https://openalex.org/W2519603001","https://openalex.org/W2527272317","https://openalex.org/W2569472942","https://openalex.org/W2582671354","https://openalex.org/W2588916311","https://openalex.org/W2606604537","https://openalex.org/W2615656344","https://openalex.org/W2622477796","https://openalex.org/W2751752943","https://openalex.org/W2771737095","https://openalex.org/W2772792314","https://openalex.org/W2777192533","https://openalex.org/W2790568323","https://openalex.org/W2792717752","https://openalex.org/W2793782219","https://openalex.org/W2794182884","https://openalex.org/W2795262817","https://openalex.org/W2799419532","https://openalex.org/W2891760302","https://openalex.org/W2892142026"],"related_works":["https://openalex.org/W2947269397","https://openalex.org/W3162456498","https://openalex.org/W7140505338","https://openalex.org/W4292560091","https://openalex.org/W3022196583","https://openalex.org/W4289755000","https://openalex.org/W2919228285","https://openalex.org/W2793782219","https://openalex.org/W4390126388","https://openalex.org/W3031955049"],"abstract_inverted_index":{"Background:":[0],"Despite":[1,249],"initial":[2],"promising":[3],"results,":[4],"the":[5,67,70,100,174,177,261],"IMvigor211":[6],"clinical":[7],"trial":[8],"failed":[9],"to":[10,82,147,221],"demonstrate":[11],"an":[12],"overall":[13],"survival":[14,78],"(os)":[15],"benefit":[16],"for":[17,25,99,108,131,180,199,260],"atezolizumab":[18,62,84,181,200,255],"compared":[19,63,85,201,232],"with":[20,42,64,86,104,188,202,212,233,240],"chemotherapy":[21,65,87,183,203],"as":[22],"second-line":[23,262],"treatment":[24,149,263],"metastatic":[26],"bladder":[27],"cancer":[28],"(mbc).":[29],"However,":[30],"given":[31],"lessened":[32,250],"adverse":[33],"events":[34],"(aes)":[35],"and":[36,121,135,152,159,166,182,186,193,252],"preserved":[37,253],"quality":[38],"of":[39,61,69,191,210,216,230,264],"life":[40],"(qol)":[41],"atezolizumab,":[43],"there":[44],"might":[45],"still":[46],"be":[47],"investment":[48],"value.":[49],"To":[50],"evaluate":[51,83],"that":[52],"potential":[53],"value,":[54],"we":[55],"conducted":[56,98],"a":[57,89,222,237,241],"cost-utility":[58],"analysis":[59,96,209,229],"(cua)":[60],"from":[66],"perspective":[68],"Canadian":[71,129,163],"health":[72],"care":[73,137],"payer.":[74],"Methods:":[75],"A":[76],"partitioned":[77],"model":[79,153],"was":[80,97,145,204],"used":[81,146],"over":[88],"lifetime":[90],"horizon":[91,244],"(5":[92],"years).":[93],"The":[94,140,196],"base-case":[95],"intention-to-treat":[101],"(itt)":[102],"population,":[103,176],"additional":[105],"scenario":[106,160],"analyses":[107],"subgroups":[109],"by":[110],"IMvigor-defined":[111],"PD-L1":[112,213],"status.":[113],"Health":[114],"outcomes":[115],"were":[116,138,155,168,184],"evaluated":[117],"through":[118,157],"life-year":[119],"gains":[120],"quality-adjusted":[122],"life-years":[123],"(qalys).":[124],"Cost":[125],"estimates":[126],"in":[127],"2018":[128],"dollars":[130],"systemic":[132],"treatment,":[133],"aes,":[134],"end-of-life":[136],"incorporated.":[139],"incremental":[141],"cost-effectiveness":[142],"ratio":[143],"(icer)":[144],"compare":[148],"strategies.":[150],"Parameter":[151],"uncertainty":[154],"assessed":[156],"sensitivity":[158],"analyses.":[161],"Per":[162],"guidelines,":[164],"cost":[165],"effectiveness":[167],"discounted":[169],"at":[170],"1.5%.":[171],"Results:":[172],"For":[173],"itt":[175],"expected":[178,189,234],"qalys":[179],"0.75":[185],"0.56,":[187],"costs":[190],"$90,290":[192],"$8,466":[194],"respectively.":[195],"resultant":[197],"icer":[198,224],"$430,652":[205],"per":[206,226,246],"qaly.":[207],"Scenario":[208,228],"patients":[211],"expression":[214],"levels":[215],"5%":[217],"or":[218],"greater":[219],"led":[220],"lower":[223],"($334,387":[225],"qaly).":[227,247],"observed":[231],"benefits":[235],"demonstrated":[236],"higher":[238],"icer,":[239],"shorter":[242],"time":[243],"($928,950":[245],"Conclusions:":[248],"aes":[251],"qol,":[254],"is":[256],"not":[257],"considered":[258],"cost-effective":[259],"mbc.":[265]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2020-09-11T00:00:00"}